
    
      PROTOCOL OUTLINE:

      This is a randomized, double-blind study. Patients are stratified by prior/concurrent medical
      management.

      Patients in the first group are treated with oral methotrexate 3 times a week and a daily
      oral placebo.

      Patients in the second group are treated with daily oral colchicine and an oral placebo 3
      times a week.

      Therapy continues for 10 years. Beginning year 2, daily oral ursodiol is administered to all
      patients. Patients with disease progression are crossed to the alternate group or undergo
      liver transplantation if clinically indicated.
    
  